<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04650997</url>
  </required_header>
  <id_info>
    <org_study_id>HSEARS20110215003</org_study_id>
    <nct_id>NCT04650997</nct_id>
  </id_info>
  <brief_title>The Mechanical,Physiological and Therapeutic Effects of Eccentric Exercise Combined With Extracorporeal Shockwave Therapy in Athletes With Patellar Tendinopathy</brief_title>
  <official_title>The Mechanical,Physiological and Therapeutic Effects of Eccentric Exercise Combined With Extracorporeal Shockwave Therapy in Athletes With Patellar Tendinopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hong Kong Polytechnic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hong Kong Polytechnic University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patellar tendinopathy is one of the most common injuries in jumping athletes. Changes in&#xD;
      mechanical and physiological properties of tendon are the two proposed forms of pathogenesis.&#xD;
      The efficacy of eccentric exercise when applied alone and combined with extrocoporeal&#xD;
      shockwave therapy had been reported; however, the underlying treatment mechanisms of pain and&#xD;
      dysfunction are not clear. This project aimed to explore the mechanical, physiological and&#xD;
      therapeutic effects of eccentric exercise when applied as a single treatment and as an&#xD;
      adjunct to extracorporeal shockwave therapy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 16, 2011</start_date>
  <completion_date type="Actual">January 1, 2014</completion_date>
  <primary_completion_date type="Actual">January 1, 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tendon stress in pascals at baseline</measure>
    <time_frame>Before intervention</time_frame>
    <description>Tendon stress measured by ultrasonography and dynamometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of tendon stress in pascals at 12 weeks</measure>
    <time_frame>12 weeks</time_frame>
    <description>Tendon stress measured by ultrasonography and dynamometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of tendon stress in pascals at 16 weeks</measure>
    <time_frame>16 weeks</time_frame>
    <description>Tendon stress measured by ultrasonography and dynamometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tendon vascularity index as percentage at baseline</measure>
    <time_frame>Before intervention</time_frame>
    <description>Tendon vascularity measured by power doppler ultrasonography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of tendon vascularity index as percentage at 12 weeks</measure>
    <time_frame>12 weeks</time_frame>
    <description>Tendon vascularity measured by power doppler ultrasonography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of tendon vascularity index as percentage at 16 weeks</measure>
    <time_frame>16 weeks</time_frame>
    <description>Tendon vascularity measured by power doppler ultrasonography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tendon related pain on visual analogy scale at baseline</measure>
    <time_frame>Before intervention</time_frame>
    <description>Maximal intensity of self-perceived pain in the past 7 days, pain during single-leg declined-squat test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of tendon related pain on visual analogy scale at 12 weeks</measure>
    <time_frame>12 weeks</time_frame>
    <description>Maximal intensity of self-perceived pain in the past 7 days, pain during single-leg declined-squat test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of tendon related pain on visual analogy scale at 16 weeks</measure>
    <time_frame>16 weeks</time_frame>
    <description>Maximal intensity of self-perceived pain in the past 7 days, pain during single-leg declined-squat test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tendon related dysfunction by questionnaire at baseline</measure>
    <time_frame>Before intervention</time_frame>
    <description>Victorian Institute of Sport Assessment Questionnaire - Patellar Tendon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of tendon related dysfunction by questionnaire at 12 weeks</measure>
    <time_frame>12 weeks</time_frame>
    <description>Victorian Institute of Sport Assessment Questionnaire - Patellar Tendon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of tendon related dysfunction by questionnaire at 16 weeks</measure>
    <time_frame>16 weeks</time_frame>
    <description>Victorian Institute of Sport Assessment Questionnaire - Patellar Tendon</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Patellar Tendinopathy</condition>
  <arm_group>
    <arm_group_label>Combined</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 weeks eccentric exercise combined with 6 sessions of extracorporeal shockwave therapy in the initial 6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>12 weeks eccentric exercise combined with 6 sessions of sham extracorporeal shockwave therapy in the initial 6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Eccentric exercise</intervention_name>
    <description>Knee eccentric exercise with sham or focused extrocorporeal shockwave therapy for 12 weeks</description>
    <arm_group_label>Combined</arm_group_label>
    <arm_group_label>Exercise</arm_group_label>
    <other_name>Extracoporeal shockwave therapy (Minilith SL1, Storz Medical)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Competitive athletes&#xD;
&#xD;
          -  Pain at the inferior pole of the patella with training for at least 3 months&#xD;
&#xD;
          -  Tenderness at the inferior pole of the patella on palpation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patellofemoral pain syndrome, fat pad irritations, meniscus injury, osteoarthritis,&#xD;
             rheumatoid arthritis or infections&#xD;
&#xD;
          -  History of fracture over lower limbs and inflammatory myopathies&#xD;
&#xD;
          -  Cortisone injuection and other interventions within 3 months&#xD;
&#xD;
          -  Contraindication to extracorporeal shockwave therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2011</verification_date>
  <study_first_submitted>July 30, 2020</study_first_submitted>
  <study_first_submitted_qc>November 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>November 25, 2020</last_update_submitted>
  <last_update_submitted_qc>November 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

